|
US7365093B2
(en)
*
|
1994-08-19 |
2008-04-29 |
Abbott Laboratories |
Endothelin antagonists
|
|
GB0004297D0
(en)
*
|
2000-02-23 |
2000-04-12 |
Ucb Sa |
2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
|
|
US6686477B2
(en)
|
2000-09-29 |
2004-02-03 |
Eastman Chemical Company |
Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
|
|
EP1379236A4
(en)
*
|
2001-02-23 |
2009-01-21 |
Ucb Sa |
TREATMENT OF TICS, TREMOR AND RELATED DISORDER
|
|
EP1419144B1
(en)
|
2001-08-10 |
2008-10-08 |
UCB Pharma S.A. |
Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
|
|
CA2461961A1
(en)
*
|
2001-10-08 |
2003-04-17 |
Ucb, S.A. |
Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
|
|
AU2002335015B8
(en)
|
2001-10-16 |
2006-11-30 |
Memory Pharmaceuticals Corporation |
4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
|
WO2003094913A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Ucb, S.A. |
Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
|
|
AU2004204338A1
(en)
|
2003-01-13 |
2004-07-29 |
Ucb |
Hydrogenation catalysts
|
|
WO2004069796A2
(en)
*
|
2003-02-03 |
2004-08-19 |
Teva Pharmaceutical Industries Ltd. |
Process for producing levetiracetam
|
|
ES2214147B1
(es)
|
2003-02-28 |
2005-10-01 |
Farma-Lepori S.A. |
Procedimiento de obtencion de un agente antiepileptico.
|
|
US20050143445A1
(en)
*
|
2003-03-18 |
2005-06-30 |
Parthasaradhi Reddy B. |
Novel crystalline forms of levetiracetam
|
|
RU2232578C1
(ru)
*
|
2003-04-10 |
2004-07-20 |
Ахапкина Валентина Ивановна |
Вещество, обладающее антидепрессивной активностью
|
|
SG169900A1
(en)
|
2003-04-16 |
2011-04-29 |
Memory Pharm Corp |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
|
US7034051B2
(en)
*
|
2003-08-28 |
2006-04-25 |
Adolor Corporation |
Fused bicyclic carboxamide derivatives and methods of their use
|
|
WO2005023763A1
(en)
*
|
2003-09-05 |
2005-03-17 |
Ranbaxy Laboratories Limited |
Process for the preparation of pure levetiracetam
|
|
DK1667967T3
(da)
*
|
2003-09-24 |
2012-10-08 |
Ucb Pharma Sa |
Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
|
|
ES2323313T3
(es)
|
2003-12-02 |
2009-07-13 |
Ucb Pharma, S.A. |
Derivados de imidazol, procedimientos para prepararlos y sus usos.
|
|
EP1758855B1
(en)
*
|
2004-06-11 |
2007-11-21 |
UCB Pharma, S.A. |
Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
|
|
EA200800909A1
(ru)
*
|
2004-06-21 |
2008-08-29 |
УОРНЕР-ЛАМБЕРТ КОМПАНИ ЭлЭлСи |
Получение прегабалина и родственных соединений
|
|
US7427601B2
(en)
*
|
2004-06-24 |
2008-09-23 |
Schwarz Pharma Ag |
Method for treating tremor
|
|
CA2584328A1
(en)
|
2004-10-20 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
CA2488325C
(en)
*
|
2004-11-22 |
2010-08-24 |
Apotex Pharmachem Inc. |
Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
|
|
WO2006128693A2
(en)
|
2005-06-01 |
2006-12-07 |
Ucb Pharma, S.A. |
2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
|
|
EP1731149A1
(en)
*
|
2005-06-08 |
2006-12-13 |
Ucb S.A. |
Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
|
|
AU2006291524B2
(en)
*
|
2005-09-15 |
2012-01-12 |
Ucb Pharma S.A |
4-substituted pyrrolidin-2-ones and their use
|
|
JP2007153755A
(ja)
*
|
2005-12-01 |
2007-06-21 |
Gifu Univ |
プロリン類縁体
|
|
EP1993998B1
(en)
*
|
2005-12-07 |
2013-08-21 |
UCB Pharma, S.A. |
3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
|
|
US8338621B2
(en)
|
2005-12-21 |
2012-12-25 |
Ucb S.A. |
Process for the preparation of 2-oxo-1-pyrrolidine derivatives
|
|
LV13630B
(en)
*
|
2006-03-16 |
2007-12-20 |
Olainfarm As |
Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
|
|
ES2444009T3
(es)
*
|
2006-06-08 |
2014-02-21 |
Ucb Pharma, S.A. |
Co-cristales de pirrolidinonas
|
|
KR20150003925A
(ko)
|
2006-06-15 |
2015-01-09 |
유씨비 파르마 게엠베하 |
상승적 항경련 효과를 갖는 약제학적 조성물
|
|
EP2051696A2
(en)
*
|
2006-08-18 |
2009-04-29 |
Morton Grove Pharmaceuticals, Inc. |
Stable liquid levetiracetam compositions and methods
|
|
GEP20125425B
(en)
*
|
2006-10-18 |
2012-03-26 |
Pfizer Prod Inc |
Biaryl ether urea compounds
|
|
WO2008103319A2
(en)
|
2007-02-16 |
2008-08-28 |
Ark Diagnostics, Inc. |
Compounds and methods for use in detecting gabapentin
|
|
WO2008132142A2
(en)
*
|
2007-04-27 |
2008-11-06 |
Ucb Pharma S.A. |
New heterocyclic derivatives useful for the treatment of cns disorders
|
|
US20090082422A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched levetiracetam
|
|
EP2273975B8
(en)
*
|
2008-03-03 |
2014-12-17 |
UCB Pharma, S.A. |
Pharmaceutical solutions, process of preparation and therapeutic uses
|
|
US7741327B2
(en)
*
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
WO2010002869A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
2-oxo-1-pyrrolidine derivatives
|
|
EP2147911A1
(en)
|
2008-07-24 |
2010-01-27 |
ZaCh System S.p.A. |
Process for the preparation of levetiracetam
|
|
JP4644881B2
(ja)
|
2008-09-19 |
2011-03-09 |
高砂香料工業株式会社 |
ルテニウム錯体の製造方法
|
|
BRPI0920342A2
(pt)
|
2008-10-16 |
2020-06-23 |
The Johns Hopkins University |
Uso de um inibidor da proteína vesicular sináptica 2a (sv2a) ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica para melhora da função cognitiva, uso de levitiracetam ou um sal farmaceuticamente aceitável do mesmo, uso de brivaracetam ou um sal farmaceuticamente aceitável do mesmo, uso do seletracetam ou um sal farmaceuticamente aceitável do mesmo
|
|
US8168756B2
(en)
|
2008-10-24 |
2012-05-01 |
Ark Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
EP2341777B1
(en)
*
|
2008-11-07 |
2015-01-21 |
NovaBay Pharmaceuticals, Inc. |
Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
|
|
EA019583B1
(ru)
*
|
2008-11-18 |
2014-04-30 |
Юсб Фарма, С.А. |
Композиции с пролонгированным высвобождением, содержащие производное 2-оксо-1-пирролидина
|
|
AU2009317280B2
(en)
*
|
2008-11-18 |
2014-03-06 |
Ucb Pharma, S.A. |
Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative
|
|
FR2939311A1
(fr)
*
|
2008-12-08 |
2010-06-11 |
Oreal |
Utilisation d'un derive diester de pyrrolidinone 4-carboxy comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
|
|
US8563036B2
(en)
|
2009-02-09 |
2013-10-22 |
Ucb Pharma, S.A. |
Pharmaceutical compositions comprising Brivaracetam
|
|
US8846411B2
(en)
*
|
2009-06-11 |
2014-09-30 |
Microgenics Corporation |
Derivatives, reagents, and immunoassay for detecting levetiracetam
|
|
EP2461808A2
(en)
|
2009-08-07 |
2012-06-13 |
UCB Pharma S.A. |
Methods for enhancing the cognitive function
|
|
US7939676B2
(en)
|
2009-09-17 |
2011-05-10 |
Zach System S.P.A. |
Process for the preparation of levetiracetam
|
|
US8487591B1
(en)
|
2009-12-31 |
2013-07-16 |
Cirrus Logic, Inc. |
Power control system with power drop out immunity and uncompromised startup time
|
|
HUE028668T2
(en)
|
2009-10-23 |
2016-12-28 |
Ucb Biopharma Sprl |
2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
|
|
PL389364A1
(pl)
|
2009-10-23 |
2011-04-26 |
Uniwersytet Jagielloński |
Nowe zastosowanie pochodnych 2-pirolidonu
|
|
EP2533645B1
(en)
|
2010-02-09 |
2016-07-27 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
FR2961101B1
(fr)
|
2010-06-09 |
2013-01-25 |
Oreal |
Composition comprenant au moins une 2-pyrrolidone fonctionnalisee par un radical ester ou amide, et au moins un pigment ou un colorant direct pour la teinture des matieres keratiniques
|
|
FR2961098A1
(fr)
|
2010-06-09 |
2011-12-16 |
Oreal |
Composition comprenant au moins une 2-pyrrolidone fonctionnalisee en position 4 par un acide carboxylique ou amide, et au moins un colorant direct ou un pigment pour la teinture des fibres keratiniques
|
|
FR2961099B1
(fr)
|
2010-06-09 |
2012-06-15 |
Oreal |
Derives de 2-pyrrolidone fonctionnalisee par un radical ester, acide ou amide, la composition cosmetique les comprenant et leur utilisation pour le conditionnement des matieres keratiniques
|
|
US8466297B2
(en)
|
2010-11-01 |
2013-06-18 |
Milan Soukup |
Manufacturing process for (S)-Pregabalin
|
|
NO3034079T3
(enExample)
|
2010-11-15 |
2018-06-09 |
|
|
|
EP2672822A4
(en)
*
|
2011-02-09 |
2014-08-27 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS
|
|
WO2012143117A1
(en)
|
2011-04-18 |
2012-10-26 |
Ucb Pharma, S.A. |
2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
|
|
CN103906745B
(zh)
|
2011-09-30 |
2017-08-25 |
塔夫斯大学 |
用于治疗神经变性疾病的尿苷二磷酸衍生物、组合物和方法
|
|
BR112014015482A8
(pt)
*
|
2011-12-27 |
2017-07-04 |
Bio Pharm Solutions Co Ltd |
compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
|
|
TW201408293A
(zh)
*
|
2012-07-05 |
2014-03-01 |
Merz Pharma Gmbh & Co Kgaa |
(r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
|
|
TW201408294A
(zh)
*
|
2012-07-05 |
2014-03-01 |
Merz Pharma Gmbh & Co Kgaa |
(r)-苯基披喇瑟盪於治療帕金森氏症之用除
|
|
JP6523958B2
(ja)
|
2012-09-28 |
2019-06-05 |
タフツ・ユニバーシティ |
ウリジン二リン酸誘導体、プロドラッグ、組成物およびそれらの使用
|
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
WO2014088984A1
(en)
*
|
2012-12-07 |
2014-06-12 |
Merck Sharp & Dohme Corp. |
Biocatalytic transamination process
|
|
WO2014087367A2
(en)
*
|
2012-12-09 |
2014-06-12 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological diseases and its associated complications
|
|
US9970929B2
(en)
|
2013-01-18 |
2018-05-15 |
Ark Diagnostics, Inc. |
Voriconazole immunoassays
|
|
ES2674704T3
(es)
|
2013-02-13 |
2018-07-03 |
Ark Diagnostics, Inc. |
Inmunoensayos de posaconazol
|
|
US10138265B2
(en)
|
2013-03-13 |
2018-11-27 |
Tufts University |
Uridine nucleoside derivatives, compositions and methods of use
|
|
HUE039871T2
(hu)
|
2013-03-13 |
2019-02-28 |
Univ Tufts |
Uridin nukleozid származékok, kompozíciók és alkalmazási eljárások
|
|
CN105142623A
(zh)
|
2013-03-15 |
2015-12-09 |
艾吉因生物股份有限公司 |
用于改善认知功能的方法和组合物
|
|
EP2968237A4
(en)
|
2013-03-15 |
2016-08-31 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
|
|
CN103342672B
(zh)
*
|
2013-07-02 |
2015-12-23 |
扬州大学 |
取代吡咯烷-2-酮的新合成方法
|
|
JP6453632B2
(ja)
*
|
2013-12-05 |
2019-01-16 |
株式会社日本触媒 |
環状アミドアクリレート含有組成物およびその製造方法
|
|
JP6465634B2
(ja)
*
|
2013-12-05 |
2019-02-06 |
株式会社日本触媒 |
環状アミド基含有重合体
|
|
US10329301B2
(en)
|
2013-12-20 |
2019-06-25 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
PT3096790T
(pt)
|
2014-01-21 |
2019-10-15 |
Janssen Pharmaceutica Nv |
Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso
|
|
EA202192105A3
(ru)
|
2014-02-04 |
2022-02-28 |
Янссен Фармацевтика Нв |
Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение
|
|
CN104098497B
(zh)
*
|
2014-06-17 |
2016-04-13 |
王庚禹 |
一种新的酰胺类化合物
|
|
WO2016075082A1
(en)
|
2014-11-10 |
2016-05-19 |
Sandoz Ag |
Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
|
|
WO2016131947A1
(en)
|
2015-02-20 |
2016-08-25 |
Ucb Biopharma Sprl |
Combination treatment
|
|
CN106279074B
(zh)
*
|
2015-05-25 |
2018-06-26 |
苏州鹏旭医药科技有限公司 |
一种化合物及其制备方法和在合成布瓦西坦中的用途
|
|
CN106365986B
(zh)
*
|
2015-07-21 |
2019-01-08 |
苏州鹏旭医药科技有限公司 |
化合物及其制备方法和在合成布瓦西坦中的用途
|
|
MX380263B
(es)
*
|
2015-05-25 |
2025-03-12 |
Suzhou Pengxu Pharmatech Co Ltd |
Procesos para producir brivaracetam.
|
|
JP6948708B2
(ja)
|
2015-06-19 |
2021-10-13 |
センチュリオン バイオファーマ コーポレイション |
薬物制御放出のための送達系
|
|
CA2990004C
(en)
|
2015-06-19 |
2024-04-23 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
WO2017076737A1
(en)
|
2015-11-03 |
2017-05-11 |
Ucb Biopharma Sprl |
Continuous process for preparing brivaracetam
|
|
EP3371150B1
(en)
|
2015-11-03 |
2021-08-18 |
UCB Biopharma SRL |
Process for preparing brivaracetam
|
|
CN106748748B
(zh)
*
|
2015-11-10 |
2021-08-24 |
成都国为生物医药有限公司 |
一种布瓦西坦的制备方法及其中间体
|
|
CN105646319B
(zh)
*
|
2015-12-30 |
2018-05-18 |
佛山市隆信医药科技有限公司 |
一种布瓦西坦的制备方法
|
|
EP3397253A1
(en)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
US20210220331A1
(en)
|
2016-05-03 |
2021-07-22 |
The Regents Of The University Of California |
Inhibitors of ires-mediated protein synthesis
|
|
RU2629117C1
(ru)
*
|
2016-06-14 |
2017-08-24 |
Сизов Владимир Владимирович |
Способ получения 4-замещенного 2-[2-оксо-1-пирролидинил] ацетамида
|
|
CN107513031B
(zh)
*
|
2016-06-16 |
2022-08-02 |
上海医药集团股份有限公司 |
一种2-氧代-1-吡咯烷手性衍生物的制备方法
|
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
EP3571183B1
(en)
|
2017-01-20 |
2024-03-06 |
The Regents of the University of California |
3-(phenyl)-2-(aminomethyl)-1-phenyl-2-propen-1-one derivatives as inhibitors of the n-terminal domain of the androgen receptor for treating prostate cancer
|
|
WO2018141276A1
(zh)
*
|
2017-02-05 |
2018-08-09 |
苏州鹏旭医药科技有限公司 |
布瓦西坦中间体的晶型a及其制备方法和布瓦西坦的晶型c及其制备方法
|
|
CN106866483A
(zh)
*
|
2017-02-05 |
2017-06-20 |
苏州鹏旭医药科技有限公司 |
布瓦西坦的晶型c及其制备方法
|
|
CN108503610B
(zh)
|
2017-02-24 |
2019-09-13 |
北京艾百诺医药股份有限公司 |
一种光学纯的(r)-4-正丙基-二氢呋喃-2(3h)-酮的制备方法
|
|
CN108658831B
(zh)
*
|
2017-03-30 |
2021-11-05 |
江苏豪森药业集团有限公司 |
2-氧代-1-吡咯烷衍生物或其盐的制备方法
|
|
CN110753684A
(zh)
|
2017-04-24 |
2020-02-04 |
特沙诺有限公司 |
尼拉帕利的制造方法
|
|
JP7221227B2
(ja)
|
2017-06-30 |
2023-02-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
発毛を調節するための組成物及び方法
|
|
AU2018341454B2
(en)
|
2017-09-26 |
2023-09-28 |
The Regents Of The University Of California |
Compositions and methods for treating cancer
|
|
CN107793342A
(zh)
*
|
2017-10-19 |
2018-03-13 |
丽珠集团新北江制药股份有限公司 |
一种布瓦西坦的制备方法
|
|
CN107721896A
(zh)
*
|
2017-10-19 |
2018-02-23 |
丽珠集团新北江制药股份有限公司 |
一种布瓦西坦的中间体的制备方法
|
|
BR112020009836A2
(pt)
|
2017-11-30 |
2020-10-13 |
Centurion Biopharma Corporation |
pró-drogas de ligação a albumina de derivados de auristatina e
|
|
MX2020005472A
(es)
|
2017-11-30 |
2020-11-11 |
Centurion Biopharma Corp |
Sistemas de administración de fármacos a base de maitansinoide.
|
|
US11708329B2
(en)
|
2018-01-30 |
2023-07-25 |
The Regents Of The University Of California |
Inhibitors of the WNT/beta-catenin pathway
|
|
CN108147988B
(zh)
*
|
2018-02-13 |
2020-10-02 |
扬州奥锐特药业有限公司 |
一种高手性纯度内酰胺化合物的制备方法
|
|
CN108530402B
(zh)
*
|
2018-04-10 |
2020-06-26 |
浙江工业大学 |
一种(R)-3-丙基-γ-丁内酯的制备方法
|
|
EP3566760A1
(en)
*
|
2018-05-07 |
2019-11-13 |
Universite Libre De Bruxelles |
Method for nucleating crystals from a solution in a capillary tube
|
|
ES2947618T3
(es)
|
2018-05-08 |
2023-08-14 |
UCB Biopharma SRL |
Derivados de 1-imidazotiadiazolo-2H-pirrol-5-ona
|
|
BR112020026062B1
(pt)
|
2018-06-19 |
2023-04-04 |
Agenebio, Inc |
Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
|
|
CN110615744B
(zh)
|
2018-06-20 |
2023-01-06 |
上海朴颐化学科技有限公司 |
一种布瓦西坦中间体及其制备方法
|
|
US20210122771A1
(en)
|
2018-06-29 |
2021-04-29 |
The Regents Of The University Of California |
New molecular tweezers against neurological disorders and viral infections
|
|
RU2699669C1
(ru)
*
|
2018-07-04 |
2019-09-09 |
Общество С Ограниченной Ответственностью "Валента - Интеллект" |
Новые составы N-карбамоилметил-4-фенил-2-пирролидона
|
|
AU2019310595B2
(en)
|
2018-07-27 |
2022-11-24 |
1200 Pharma Llc |
CDK inhibitors and uses thereof
|
|
EP3867223B1
(en)
|
2018-10-17 |
2025-12-10 |
The Regents of the University of California |
Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof
|
|
EP3699173A1
(en)
|
2018-10-18 |
2020-08-26 |
California Institute of Technology |
Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same
|
|
US12274898B2
(en)
|
2018-10-31 |
2025-04-15 |
Intocell, Inc. |
Substituted benzodiazepines as antibody-drug conjugates
|
|
EP3890833B1
(en)
|
2018-12-04 |
2023-06-07 |
Metys Pharmaceuticals AG |
Synergistic compositions comprising (r)-2-(2-oxopyrrolidin-1-yl)butanamide and (s)-2-(2-oxopyrrolidin-1-yl)butanamide in a non-racemic ratio
|
|
WO2020176386A2
(en)
|
2019-02-25 |
2020-09-03 |
The Regents Of The University Of California |
Methods of carbon-carbon bond fragmentation
|
|
CN109932442A
(zh)
*
|
2019-03-04 |
2019-06-25 |
成都美域高制药有限公司 |
一种布瓦西坦异构体的检测方法
|
|
IL318073A
(en)
|
2019-03-25 |
2025-02-01 |
California Inst Of Techn |
PRMT5 inhibitors and their uses
|
|
KR20220016918A
(ko)
|
2019-06-04 |
2022-02-10 |
하거 바이오사이언시즈, 엘엘씨 |
오렉신 길항제로서의 이미다졸로 유도체, 조성물 및 방법
|
|
CN110357752A
(zh)
*
|
2019-08-15 |
2019-10-22 |
中国工程物理研究院化工材料研究所 |
一种快速制备均匀包覆含能材料的方法
|
|
RU2732245C1
(ru)
*
|
2019-08-30 |
2020-09-14 |
Ооо "Валента-Интеллект" |
Новые составы n-карбамоилметил-4-фенил-2-пирролидона для лечения и профилактики ожирения
|
|
CN110551050A
(zh)
*
|
2019-09-02 |
2019-12-10 |
南通大学 |
一种2-[3’-(N-Boc-吡咯基)]-苯甲酸的合成方法
|
|
US10781170B1
(en)
|
2019-10-21 |
2020-09-22 |
Divi's Laboratories Ltd. |
Process for preparing Brivaracetam
|
|
US20230100559A1
(en)
|
2020-01-07 |
2023-03-30 |
The Trustees Of Princeton University |
Compositions and Methods for Treatment of Disease by Manipulation of Serine Metabolism
|
|
WO2021142221A1
(en)
|
2020-01-10 |
2021-07-15 |
The Regents Of The University Of California |
Compositions and methods for the treatment of neurodegenerative diseases
|
|
US20230174460A1
(en)
|
2020-04-21 |
2023-06-08 |
President And Fellowes Of Harvard College |
Afmt analogs and their use in methods of treating parkinson's disease
|
|
LV15614A
(lv)
|
2020-07-30 |
2022-02-20 |
Latvijas Organiskās Sintēzes Institūts |
2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi
|
|
AU2021326457A1
(en)
|
2020-08-10 |
2023-03-16 |
Dana-Farber Cancer Institute, Inc. |
Fused tricyclic pyrimidine-thieno-pyridine small molecule inhibitors of ubiquitin-specific protease 28
|
|
CA3191164A1
(en)
|
2020-08-10 |
2022-02-17 |
Dana-Farber Cancer Institute, Inc. |
Substituted 1,2,4-oxadiazoles as small molecule inhibitors of ubiquitin-specific protease 28
|
|
US20230271918A1
(en)
|
2020-08-10 |
2023-08-31 |
Dana-Farber Cancer Institute, Inc. |
Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28
|
|
IL301627A
(en)
*
|
2020-10-06 |
2023-05-01 |
De Shaw Res Llc |
LACTAM COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
|
|
EP4232161A1
(en)
|
2020-10-23 |
2023-08-30 |
Dana-Farber Cancer Institute, Inc. |
Covalent inhibitors of creatine kinase (ck) and uses thereof for treating and preventing cancer
|
|
US20240058344A1
(en)
|
2020-12-18 |
2024-02-22 |
Cornell University |
Methods of treating neurodegenerative disorders and stat3-linked cancers using suppressors of electron leak
|
|
IL303813A
(en)
|
2020-12-21 |
2023-08-01 |
Univ Cornell |
Peptide-linked drug delivery system
|
|
WO2022150574A1
(en)
|
2021-01-08 |
2022-07-14 |
Cornell University |
Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase
|
|
US11400074B1
(en)
|
2021-02-01 |
2022-08-02 |
Divi's Laboratories Ltd. |
Enzymatic process for the preparation of (2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam
|
|
US11384050B1
(en)
|
2021-02-03 |
2022-07-12 |
Vitaworks Ip, Llc |
Method for preparing levetiracetam and intermediates thereof
|
|
CN114948953A
(zh)
*
|
2021-06-29 |
2022-08-30 |
四川大学华西医院 |
一种杂原子取代芳香类化合物及其盐的用途
|
|
CN113511994B
(zh)
*
|
2021-08-16 |
2023-03-21 |
江苏八巨药业有限公司 |
一种左乙拉西坦的制备方法
|
|
CN114634437B
(zh)
*
|
2022-03-29 |
2023-05-30 |
武汉氟本氘合新材料科技有限公司 |
一种布瓦西坦的简易制备方法
|
|
US11884623B2
(en)
|
2022-05-23 |
2024-01-30 |
Divi's Laboratories Ltd. |
Process for the preparation of (R)-4-propyl pyrrolidine-2-one, a key intermediate for synthesis of brivaracetam
|
|
WO2023250157A1
(en)
|
2022-06-24 |
2023-12-28 |
Cornell University |
Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase
|
|
JP2025525415A
(ja)
|
2022-07-13 |
2025-08-05 |
アストラゼネカ・アクチエボラーグ |
Ｐｃｓｋ９阻害剤およびその使用方法
|
|
EP4572852A1
(en)
|
2022-08-19 |
2025-06-25 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
WO2024049236A1
(ko)
*
|
2022-08-31 |
2024-03-07 |
고려대학교 산학협력단 |
키랄 감마 락탐 유도체 또는 이의 약학적으로 허용가능한 염 및 이의 제조방법
|
|
WO2024163711A1
(en)
|
2023-02-02 |
2024-08-08 |
Osmoses Inc. |
Norbornyl benzocyclobutene ladder polymer composite membranes for fluid separation
|
|
CN116041240B
(zh)
|
2023-02-17 |
2024-04-09 |
扬州奥锐特药业有限公司 |
布立西坦中间体的不对称催化氢化合成方法
|
|
EP4431086A1
(en)
|
2023-03-16 |
2024-09-18 |
Adalvo Limited |
Pharmaceutical composition comprising (2s)-2-[(4r)-2-oxo-4-propyltetrahydro-1h-pyrrol-1-yl]butanamide
|
|
WO2025078883A2
(en)
|
2023-05-06 |
2025-04-17 |
Prepaire Labs Limited |
Organic compound (oxime) to combat chemical warfare agents
|
|
WO2025064475A2
(en)
|
2023-09-18 |
2025-03-27 |
Flagship Pioneering Innovations Vii, Llc |
Ionizable lipidoid compositions and therapeutic uses thereof
|
|
WO2025072893A1
(en)
|
2023-09-29 |
2025-04-03 |
Battelle Memorial Institute |
Polymer nanoparticle compositions for non-viral gene delivery
|
|
WO2025072751A1
(en)
|
2023-09-29 |
2025-04-03 |
Battelle Memorial Institute |
Polymer nanoparticle compositions for in vivo expression of polypeptides
|
|
US20250162981A1
(en)
|
2023-11-14 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Ionizable lipidoid compositions and therapeutic uses thereof
|
|
WO2025231452A1
(en)
|
2024-05-02 |
2025-11-06 |
Martinez Montemayor Michelle |
Ergosterol peroxide derivatives and uses thereof
|